Ishihara T, Igarashi I, Kitano T, Shinzato T, Maeda K
Toyota Central R&D Laboratories, Aichi, Japan.
Artif Organs. 1993 Aug;17(8):708-16. doi: 10.1111/j.1525-1594.1993.tb00619.x.
A two-frequency electrical conductivity method for measuring hematocrit has been developed for use in the continuous monitoring of circulating blood volume during artificial kidney treatment. Using this method, an algorithm for programmed control of blood volume also has been developed. This hematocrit measurement method is based on the beta-dispersion of blood conductivity, and the values measured during hemodialysis are in good agreement with the laboratory hematocrit values obtained by a Coulter counter. Programmed control of blood volume was used 29 times on 11 patients undergoing long-term dialysis. In each case, the blood volume was maintained within 2.5% of the desired level, and stable control was achieved even with disturbances caused by eating, change in body position, and so on. These methods can be used to study the relationship between blood volume and dialysis-induced hypotension during artificial kidney treatment and to achieve adequate ultrafiltration without clinical adverse effects.
已开发出一种用于测量血细胞比容的双频电导率方法,用于在人工肾治疗期间连续监测循环血容量。利用该方法,还开发了一种用于血容量程控的算法。这种血细胞比容测量方法基于血液电导率的β-色散,并且在血液透析期间测得的值与通过库尔特计数器获得的实验室血细胞比容值高度一致。对11名接受长期透析的患者使用血容量程控29次。在每种情况下,血容量均维持在期望水平的2.5%以内,即使存在因进食、体位改变等引起的干扰,也能实现稳定控制。这些方法可用于研究人工肾治疗期间血容量与透析引起的低血压之间的关系,并实现充分超滤而无临床不良反应。